{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:02:06Z","timestamp":1793422926594,"version":"4.5.0"},"reference-count":224,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"S\u00e3o Paulo Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"S\u00e3o Paulo Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Coordination for the Improvement of Higher Education Personnel (CAPES)"},{"DOI":"10.13039\/501100001807","name":"S\u00e3o Paulo Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Council for Scientific and Technological Development (CNPq) Brazil","id":[{"id":"https:\/\/ror.org\/03swz6y49","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Council for Scientific and Technological Development (CNPq) Brazil","id":[{"id":"https:\/\/ror.org\/03swz6y49","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-025-03532-y","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T16:24:10Z","timestamp":1755966250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Modulation of neuroimmune cytokine networks by antidepressants: implications in mood regulation"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7415-2136","authenticated-orcid":false,"given":"Roseane Galdioli","family":"Nava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anny Silva","family":"Adri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor Salerno","family":"Filgueiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriel Leal","family":"N\u00f3bile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Mar\u00e7al","family":"Barcelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohan Lucas Gon\u00e7alves","family":"Corr\u00eaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio Felipe","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Cabral-Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroldo Dutra","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena F.","family":"Schimke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"de Ara\u00fajo Gleizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1688-6155","authenticated-orcid":false,"given":"Rodrigo Juliani Siqueira","family":"Dalmolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helder I.","family":"Nakaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3998-8012","authenticated-orcid":false,"given":"Rafael Machado","family":"Rezende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3183-6236","authenticated-orcid":false,"given":"Otavio","family":"Cabral-Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,23]]},"reference":[{"key":"3532_CR1","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1600-0447.2004.00335.x","volume":"110","author":"J Spijker","year":"2004","unstructured":"Spijker J, Graaf R, Bijl RV, Beekman ATF, Ormel J, Nolen WA. Functional disability and depression in the general population. Results from the Netherlands mental health survey and incidence study (NEMESIS). Acta Psychiatr Scand. 2004;110:208\u201314.","journal-title":"Acta Psychiatr Scand"},{"key":"3532_CR2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1146\/annurev-publhealth-031912-114409","volume":"34","author":"RC Kessler","year":"2013","unstructured":"Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annu Rev Public Health. 2013;34:119\u201338.","journal-title":"Annu Rev Public Health"},{"key":"3532_CR3","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","volume":"380","author":"T Vos","year":"2012","unstructured":"Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2163\u201396.","journal-title":"Lancet"},{"key":"3532_CR4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1056\/NEJMra1110827","volume":"369","author":"AE Becker","year":"2013","unstructured":"Becker AE, Kleinman A. Mental health and the global agenda. N Engl J Med. 2013;369:66\u201373.","journal-title":"N Engl J Med"},{"key":"3532_CR5","doi-asserted-by":"publisher","first-page":"954644","DOI":"10.3389\/fmed.2022.954644","volume":"9","author":"A Aguilar-Latorre","year":"2022","unstructured":"Aguilar-Latorre A, P\u00e9rez Algorta G, Navarro-Guzm\u00e1n C, Serrano-Ripoll MJ, Oliv\u00e1n-Bl\u00e1zquez B. Effectiveness of a lifestyle modification programme in the treatment of depression symptoms in primary care. Front Med. 2022;9:954644. https:\/\/doi.org\/10.3389\/fmed.2022.954644.","journal-title":"Front Med"},{"key":"3532_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41392-024-01738-y","volume":"9","author":"L Cui","year":"2024","unstructured":"Cui L, Li S, Wang S, Wu X, Liu Y, Yu W, et al. Major depressive disorder: hypothesis, mechanism, prevention and treatment. Signal Transduct Target Ther. 2024;9:30.","journal-title":"Signal Transduct Target Ther"},{"key":"3532_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bbr.2013.10.011","volume":"258","author":"H de Morais","year":"2014","unstructured":"de Morais H, de Souza CP, da Silva LM, Ferreira DM, Werner MF, Andreatini R, et al. Increased oxidative stress in prefrontal cortex and hippocampus is related to depressive-like behavior in streptozotocin-diabetic rats. Behav Brain Res. 2014;258:52\u201364.","journal-title":"Behav Brain Res"},{"key":"3532_CR8","doi-asserted-by":"publisher","first-page":"E8460","DOI":"10.1073\/pnas.1800431115","volume":"115","author":"JO Early","year":"2018","unstructured":"Early JO, Menon D, Wyse CA, Cervantes-Silva MP, Zaslona Z, Carroll RG, et al. Circadian clock protein BMAL1 regulates IL-1\u03b2 in macrophages via NRF2. Proc Natl Acad Sci USA. 2018;115:E8460\u2013E8468. https:\/\/doi.org\/10.1073\/pnas.1800431115.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3532_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16143-6","volume":"11","author":"KS Beckwith","year":"2020","unstructured":"Beckwith KS, Beckwith MS, Ullmann S, S\u00e6tra RS, Kim H, Marstad A, et al. Plasma membrane damage causes NLRP3 activation and pyroptosis during Mycobacterium tuberculosis infection. Nat Commun. 2020;11:2270.","journal-title":"Nat Commun"},{"key":"3532_CR10","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/cns.12230","volume":"20","author":"E Alcocer\u2010G\u00f3mez","year":"2014","unstructured":"Alcocer\u2010G\u00f3mez E, Cordero MD. <scp>NLRP<\/scp> 3 inflammasome: a new target in major depressive disorder. CNS Neurosci Ther. 2014;20:294\u20135.","journal-title":"CNS Neurosci Ther"},{"key":"3532_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1761-4","volume":"10","author":"L Sun","year":"2019","unstructured":"Sun L, Ma W, Gao W, Xing Y, Chen L, Xia Z, et al. Propofol directly induces caspase-1-dependent macrophage pyroptosis through the NLRP3-ASC inflammasome. Cell Death Dis. 2019;10:542.","journal-title":"Cell Death Dis"},{"key":"3532_CR12","doi-asserted-by":"publisher","first-page":"H880","DOI":"10.1152\/ajpheart.00643.2021","volume":"322","author":"JL Greaney","year":"2022","unstructured":"Greaney JL, Saunders EFH, Alexander LM. Short-term salicylate treatment improves microvascular endothelium-dependent dilation in young adults with major depressive disorder. Am J Physiol Heart Circ Physiol. 2022;322:H880\u2013H889.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3532_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12035-018-1051-7","volume":"56","author":"M Maes","year":"2019","unstructured":"Maes M, Landucci Bonifacio K, Morelli NR, Vargas HO, Barbosa DS, Carvalho AF, et al. Major differences in neurooxidative and neuronitrosative stress pathways between major depressive disorder and types I and II bipolar disorder. Mol Neurobiol. 2019;56:141\u201356.","journal-title":"Mol Neurobiol"},{"key":"3532_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s42003-022-03051-2","volume":"5","author":"B Chen","year":"2022","unstructured":"Chen B, Zhang M, Ji M, Zhang D, Chen B, Gong W, et al. The neuroprotective mechanism of lithium after ischaemic stroke. Commun Biol. 2022;5:105.","journal-title":"Commun Biol"},{"key":"3532_CR15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.31887\/DCNS.2009.11.3\/mbelanger","volume":"11","author":"M B\u00e9langer","year":"2009","unstructured":"B\u00e9langer M, Magistretti PJ. The role of astroglia in neuroprotection. Dialogues Clin Neurosci. 2009;11:281\u201395.","journal-title":"Dialogues Clin Neurosci"},{"key":"3532_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00005-019-00543-8","volume":"67","author":"\u0141P Sza\u0142ach","year":"2019","unstructured":"Sza\u0142ach \u0141P, Lisowska KA, Cuba\u0142a WJ. The influence of antidepressants on the immune system. Arch Immunol Ther Exp (Warsz). 2019;67:143\u201351.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"3532_CR17","doi-asserted-by":"publisher","first-page":"4469","DOI":"10.3390\/molecules24244469","volume":"24","author":"LRL Diniz","year":"2019","unstructured":"Diniz LRL, Souza MTS, Barboza JN, Almeida RN, Sousa DP. Antidepressant potential of cinnamic acids: mechanisms of action and perspectives in drug development. Molecules. 2019;24:4469.","journal-title":"Molecules"},{"key":"3532_CR18","doi-asserted-by":"publisher","first-page":"429","DOI":"10.9758\/cpn.22.1034","volume":"21","author":"J Kim","year":"2023","unstructured":"Kim J, Kim T-E, Lee S-H, Koo JW. The role of glutamate underlying treatment-resistant depression. Clin Psychopharmacol Neurosci. 2023;21:429\u201346.","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"3532_CR19","doi-asserted-by":"publisher","first-page":"1118637","DOI":"10.3389\/fimmu.2023.1118637","volume":"14","author":"L Xiao","year":"2023","unstructured":"Xiao L, Li X, Fang C, Yu J, Chen T. Neurotransmitters: promising immune modulators in the tumor microenvironment. Front Immunol. 2023;14:1118637. https:\/\/doi.org\/10.3389\/fimmu.2023.1118637.","journal-title":"Front Immunol"},{"key":"3532_CR20","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.3390\/ijms24021549","volume":"24","author":"A Imamdin","year":"2023","unstructured":"Imamdin A, van der Vorst EPC. Exploring the role of serotonin as an immune modulatory component in cardiovascular diseases. Int J Mol Sci. 2023;24:1549.","journal-title":"Int J Mol Sci"},{"key":"3532_CR21","doi-asserted-by":"crossref","unstructured":"Roumier A, B\u00e9chade C, Maroteaux L. Serotonin and the immune system. In: Serotonin. Paris: Elsevier; 2019. pp. 181\u201396.","DOI":"10.1016\/B978-0-12-800050-2.00010-3"},{"key":"3532_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bbi.2019.09.016","volume":"83","author":"M Roman","year":"2020","unstructured":"Roman M, Irwin MR. Novel neuroimmunologic therapeutics in depression: a clinical perspective on what we know so far. Brain Behav Immun. 2020;83:7\u201321.","journal-title":"Brain Behav Immun"},{"key":"3532_CR23","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1038\/sj.npp.1301286","volume":"32","author":"UN Das","year":"2007","unstructured":"Das UN. Vagus nerve stimulation, depression, and inflammation. Neuropsychopharmacology. 2007;32:2053\u20134.","journal-title":"Neuropsychopharmacology"},{"key":"3532_CR24","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41586-022-05474-7","volume":"612","author":"J Rustenhoven","year":"2022","unstructured":"Rustenhoven J, Kipnis J. Brain borders at the central stage of neuroimmunology. Nature. 2022;612:417\u201329.","journal-title":"Nature"},{"key":"3532_CR25","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.immuni.2023.04.011","volume":"56","author":"F Zipp","year":"2023","unstructured":"Zipp F, Bittner S, Schafer DP. Cytokines as emerging regulators of central nervous system synapses. Immunity. 2023;56:914\u201325.","journal-title":"Immunity"},{"key":"3532_CR26","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1098\/rspb.1957.0049","volume":"147","author":"A Isaacs","year":"1957","unstructured":"Isaacs A, Lindenmann J, Valentine RC. Virus interference. II. Some properties of interferon. Proc R Soc Lond B Biol Sci. 1957;147:268\u201373.","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"3532_CR27","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1098\/rspb.1957.0048","volume":"147","author":"A Isaacs","year":"1957","unstructured":"Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci. 1957;147:258\u201367.","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"3532_CR28","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3389\/fimmu.2020.00908","volume":"11","author":"A Zlotnik","year":"2020","unstructured":"Zlotnik A. Perspective: insights on the nomenclature of cytokines and chemokines. Front Immunol. 2020;11:908. https:\/\/doi.org\/10.3389\/fimmu.2020.00908.","journal-title":"Front Immunol"},{"key":"3532_CR29","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41577-021-00508-z","volume":"21","author":"AF Salvador","year":"2021","unstructured":"Salvador AF, de Lima KA, Kipnis J. Neuromodulation by the immune system: a focus on cytokines. Nat Rev Immunol. 2021;21:526\u201341.","journal-title":"Nat Rev Immunol"},{"key":"3532_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40968-6","volume":"14","author":"MM Novakovic","year":"2023","unstructured":"Novakovic MM, Korshunov KS, Grant RA, Martin ME, Valencia HA, Budinger GRS, et al. Astrocyte reactivity and inflammation-induced depression-like behaviors are regulated by Orai1 calcium channels. Nat Commun. 2023;14:5500.","journal-title":"Nat Commun"},{"key":"3532_CR31","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H. Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther. 2023;8:267.","journal-title":"Signal Transduct Target Ther"},{"key":"3532_CR32","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.it.2007.07.005","volume":"28","author":"R Franco","year":"2007","unstructured":"Franco R, Pacheco R, Lluis C, Ahern GP, O\u2019Connell PJ. The emergence of neurotransmitters as immune modulators. Trends Immunol. 2007;28:400\u20137.","journal-title":"Trends Immunol"},{"key":"3532_CR33","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41380-022-01806-1","volume":"28","author":"GR Fries","year":"2023","unstructured":"Fries GR, Saldana VA, Finnstein J, Rein T. Molecular pathways of major depressive disorder converge on the synapse. Mol Psychiatry. 2023;28:284\u201397.","journal-title":"Mol Psychiatry"},{"key":"3532_CR34","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/ph11030064","volume":"11","author":"A Dey","year":"2018","unstructured":"Dey A, Giblin PAH. Insights into macrophage heterogeneity and cytokine-induced neuroinflammation in major depressive disorder. Pharmaceuticals. 2018;11:64. https:\/\/doi.org\/10.3390\/ph11030064.","journal-title":"Pharmaceuticals"},{"key":"3532_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0006-8993(91)90771-M","volume":"558","author":"S Ohgo","year":"1991","unstructured":"Ohgo S, Nakatsuru K, Ishikawa E, Matsukura S. Interleukin-1 (IL-1) stimulates the release of corticotropin-releasing factor (CRF) from superfused rat hypothalamo-neurohypophyseal complexes (HNC) independently of the histaminergic mechanism. Brain Res. 1991;558:217\u201323.","journal-title":"Brain Res"},{"key":"3532_CR36","doi-asserted-by":"publisher","first-page":"9317","DOI":"10.1073\/pnas.97.16.9317","volume":"97","author":"KE Bethin","year":"2000","unstructured":"Bethin KE, Vogt SK, Muglia LJ. Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation. Proc Natl Acad Sci USA. 2000;97:9317\u201322.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3532_CR37","doi-asserted-by":"publisher","first-page":"bnaa002","DOI":"10.1210\/endrev\/bnaa002","volume":"41","author":"SL Lightman","year":"2020","unstructured":"Lightman SL, Birnie MT, Conway-Campbell BL. Dynamics of ACTH and cortisol secretion and implications for disease. Endocr Rev. 2020;41:bnaa002. https:\/\/doi.org\/10.1210\/endrev\/bnaa002.","journal-title":"Endocr Rev"},{"key":"3532_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-01921-1","volume":"12","author":"V Renner","year":"2022","unstructured":"Renner V, Schellong J, Bornstein S, Petrowski K. Stress-induced pro- and anti-inflammatory cytokine concentrations in female PTSD and depressive patients. Transl Psychiatry. 2022;12:158.","journal-title":"Transl Psychiatry"},{"key":"3532_CR39","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/mp.2016.120","volume":"22","author":"J Keller","year":"2017","unstructured":"Keller J, Gomez R, Williams G, Lembke A, Lazzeroni L, Murphy GM, et al. HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition. Mol Psychiatry. 2017;22:527\u201336.","journal-title":"Mol Psychiatry"},{"key":"3532_CR40","doi-asserted-by":"publisher","first-page":"eaau9685","DOI":"10.1126\/scisignal.aau9685","volume":"12","author":"RH Oakley","year":"2019","unstructured":"Oakley RH, Cruz-Topete D, He B, Foley JF, Myers PH, Xu X, et al. Cardiomyocyte glucocorticoid and mineralocorticoid receptors directly and antagonistically regulate heart disease in mice. Sci Signal. 2019;12:eaau9685. https:\/\/doi.org\/10.1126\/scisignal.aau9685.","journal-title":"Sci Signal"},{"key":"3532_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-260","volume":"9","author":"B Chantong","year":"2012","unstructured":"Chantong B, Kratschmar DV, Nashev LG, Balazs Z, Odermatt A. Mineralocorticoid and glucocorticoid receptors differentially regulate NF-kappaB activity and pro-inflammatory cytokine production in murine BV-2 microglial cells. J Neuroinflammation. 2012;9:260.","journal-title":"J Neuroinflammation"},{"key":"3532_CR42","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41586-023-06358-0","volume":"620","author":"AM Douglass","year":"2023","unstructured":"Douglass AM, Resch JM, Madara JC, Kucukdereli H, Yizhar O, Grama A, et al. Neural basis for fasting activation of the hypothalamic\u2013pituitary\u2013adrenal axis. Nature. 2023;620:154\u201362.","journal-title":"Nature"},{"key":"3532_CR43","doi-asserted-by":"publisher","first-page":"1295261","DOI":"10.3389\/fendo.2023.1295261","volume":"14","author":"L Hantsoo","year":"2023","unstructured":"Hantsoo L, Jagodnik KM, Novick AM, Baweja R, di Scalea TL, Ozerdem A, et al. The role of the hypothalamic-pituitary-adrenal axis in depression across the female reproductive lifecycle: current knowledge and future directions. Front Endocrinol. 2023;14:1295261. https:\/\/doi.org\/10.3389\/fendo.2023.1295261.","journal-title":"Front Endocrinol"},{"key":"3532_CR44","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.bbi.2012.10.010","volume":"31","author":"JC Felger","year":"2013","unstructured":"Felger JC, Li L, Marvar PJ, Woolwine BJ, Harrison DG, Raison CL, et al. Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations. Brain Behav Immun. 2013;31:153\u201360.","journal-title":"Brain Behav Immun"},{"key":"3532_CR45","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0278-5846(01)00155-5","volume":"25","author":"BE Leonard","year":"2001","unstructured":"Leonard BE. The immune system, depression and the action of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry. 2001;25:767\u201380.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3532_CR46","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/da.22084","volume":"30","author":"AH Miller","year":"2013","unstructured":"Miller AH, Haroon E, Raison CL, Felger JC. Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress Anxiety. 2013;30:297\u2013306.","journal-title":"Depress Anxiety"},{"key":"3532_CR47","doi-asserted-by":"crossref","unstructured":"Vismari L, Jussilane Alves G, Palermo-Neto J Revis\u00e3o da literatura depress\u00e3o, antidepressivos e sistema imune: um novo olhar sobre um velho problema depression, antidepressants and immune system: a new look to an old problem. 2008.","DOI":"10.1590\/S0101-60832008000500004"},{"key":"3532_CR48","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O\u2019Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9:46\u201356.","journal-title":"Nat Rev Neurosci"},{"key":"3532_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/7854_2022_363","volume":"61","author":"R Dantzer","year":"2022","unstructured":"Dantzer R. Evolutionary aspects of infections: inflammation and sickness behaviors. Curr Top Behav Neurosci. 2022;61:1\u201314.","journal-title":"Curr Top Behav Neurosci"},{"key":"3532_CR50","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1176\/appi.ajp.157.5.683","volume":"157","author":"Z Kronfol","year":"2000","unstructured":"Kronfol Z. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry. 2000;157:683\u201394.","journal-title":"Am J Psychiatry"},{"key":"3532_CR51","doi-asserted-by":"publisher","first-page":"e209928","DOI":"10.1212\/WNL.0000000000209928","volume":"103","author":"E Benarroch","year":"2024","unstructured":"Benarroch E. What is the role of cytokines in synaptic transmission? Neurology. 2024;103:e209928. https:\/\/doi.org\/10.1212\/WNL.0000000000209928.","journal-title":"Neurology"},{"key":"3532_CR52","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri.2015.5","volume":"16","author":"AH Miller","year":"2016","unstructured":"Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16:22\u201334.","journal-title":"Nat Rev Immunol"},{"key":"3532_CR53","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.pharmthera.2011.01.014","volume":"130","author":"L Capuron","year":"2011","unstructured":"Capuron L, Miller AH. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther. 2011;130:226\u201338.","journal-title":"Pharmacol Ther"},{"key":"3532_CR54","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3390\/cells13211791","volume":"13","author":"IA Malau","year":"2024","unstructured":"Malau IA, Chang JP-C, Lin Y-W, Chang C-C, Chiu W-C, Su K-P. Omega-3 fatty acids and neuroinflammation in depression: targeting damage-associated molecular patterns and neural biomarkers. Cells. 2024;13:1791.","journal-title":"Cells"},{"key":"3532_CR55","doi-asserted-by":"crossref","unstructured":"Correa SG, Sotomayor CE, Rodr\u013aguez-Gal\u00e1n MC Cytokines and the immune\u2013neuroendocrine network. 2010. pp 79\u201390.","DOI":"10.1016\/S1567-7443(10)70012-0"},{"key":"3532_CR56","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1038\/s41423-021-00757-x","volume":"18","author":"I Galea","year":"2021","unstructured":"Galea I. The blood\u2013brain barrier in systemic infection and inflammation. Cell Mol Immunol. 2021;18:2489\u2013501.","journal-title":"Cell Mol Immunol"},{"key":"3532_CR57","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"DC Fajgenbaum","year":"2020","unstructured":"Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med. 2020;383:2255\u201373.","journal-title":"N Engl J Med"},{"key":"3532_CR58","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.3390\/brainsci11111514","volume":"11","author":"Y Kong","year":"2021","unstructured":"Kong Y, He G, Zhang X, Li J. The role of neutrophil extracellular traps in lipopolysaccharide-induced depression-like behaviors in mice. Brain Sci. 2021;11:1514.","journal-title":"Brain Sci"},{"key":"3532_CR59","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1017\/S146114570800967X","volume":"12","author":"JB O\u2019Sullivan","year":"2009","unstructured":"O\u2019Sullivan JB, Ryan KM, Curtin NM, Harkin A, Connor TJ. Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration. Int J Neuropsychopharmacol. 2009;12:687.","journal-title":"Int J Neuropsychopharmacol"},{"key":"3532_CR60","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/mp.2009.116","volume":"15","author":"CL Raison","year":"2010","unstructured":"Raison CL, Dantzer R, Kelley KW, Lawson MA, Woolwine BJ, Vogt G, et al. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-\u03b1: relationship to CNS immune responses and depression. Mol Psychiatry. 2010;15:393\u2013403.","journal-title":"Mol Psychiatry"},{"key":"3532_CR61","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2174\/1570159X14666160106155129","volume":"14","author":"E Franscina Pinto","year":"2016","unstructured":"Franscina Pinto E, Andrade C. Interferon-related depression: a primer on mechanisms, treatment, and prevention of a common clinical problem. Curr Neuropharmacol. 2016;14:743\u20138.","journal-title":"Curr Neuropharmacol"},{"key":"3532_CR62","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1177\/1073858420941476","volume":"26","author":"D Kempuraj","year":"2020","unstructured":"Kempuraj D, Selvakumar GP, Ahmed ME, Raikwar SP, Thangavel R, Khan A, et al. COVID-19, mast cells, cytokine storm, psychological stress, and neuroinflammation. Neuroscientist. 2020;26:402\u201314.","journal-title":"Neuroscientist"},{"key":"3532_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33395-6","volume":"13","author":"L Bernard-Raichon","year":"2022","unstructured":"Bernard-Raichon L, Venzon M, Klein J, Axelrad JE, Zhang C, Sullivan AP, et al. Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia. Nat Commun. 2022;13:5926.","journal-title":"Nat Commun"},{"key":"3532_CR64","doi-asserted-by":"publisher","first-page":"102177","DOI":"10.1016\/j.coi.2022.102177","volume":"76","author":"JW Bostick","year":"2022","unstructured":"Bostick JW, Schonhoff AM, Mazmanian SK. Gut microbiome-mediated regulation of neuroinflammation. Curr Opin Immunol. 2022;76:102177.","journal-title":"Curr Opin Immunol"},{"key":"3532_CR65","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","volume":"99","author":"JF Cryan","year":"2019","unstructured":"Cryan JF, O\u2019Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, et al. The microbiota-gut-brain axis. Physiol Rev. 2019;99:1877\u20132013.","journal-title":"Physiol Rev"},{"key":"3532_CR66","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1136\/gutjnl-2021-325989","volume":"71","author":"Q Liu","year":"2022","unstructured":"Liu Q, Mak JWY, Su Q, Yeoh YK, Lui GC-Y, Ng SSS, et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71:544\u201352.","journal-title":"Gut"},{"key":"3532_CR67","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1136\/gutjnl-2020-323020","volume":"70","author":"YK Yeoh","year":"2021","unstructured":"Yeoh YK, Zuo T, Lui GC-Y, Zhang F, Liu Q, Li AY, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70:698\u2013706.","journal-title":"Gut"},{"key":"3532_CR68","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature10357","volume":"477","author":"SA Villeda","year":"2011","unstructured":"Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature. 2011;477:90\u201394.","journal-title":"Nature"},{"key":"3532_CR69","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1016\/j.cell.2022.06.008","volume":"185","author":"A Fern\u00e1ndez-Casta\u00f1eda","year":"2022","unstructured":"Fern\u00e1ndez-Casta\u00f1eda A, Lu P, Geraghty AC, Song E, Lee M-H, Wood J. et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell. 2022;185:2452\u201368.e16.","journal-title":"Cell"},{"key":"3532_CR70","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.neuron.2020.06.002","volume":"107","author":"E Beurel","year":"2020","unstructured":"Beurel E, Toups M, Nemeroff CB. The bidirectional relationship of depression and inflammation: double trouble. Neuron. 2020;107:234\u201356.","journal-title":"Neuron"},{"key":"3532_CR71","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jad.2005.07.008","volume":"88","author":"A Myint","year":"2005","unstructured":"Myint A, Leonard B, Steinbusch H, Kim Y. Th1, Th2, and Th3 cytokine alterations in major depression. J Affect Disord. 2005;88:167\u201373.","journal-title":"J Affect Disord"},{"key":"3532_CR72","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/0024-3205(92)90390-B","volume":"50","author":"M Maes","year":"1992","unstructured":"Maes M, Stevens W, Peeters D, DeClerck L, Scharpe S, Bridts C, et al. A study on the blunted natural killer cell activity in severely depressed patients. Life Sci. 1992;50:505\u201313.","journal-title":"Life Sci"},{"key":"3532_CR73","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/00004714-200104000-00012","volume":"21","author":"M Kubera","year":"2001","unstructured":"Kubera M, Lin A-H, Kenis G, Bosmans E, van Bockstaele D, Maes M. Anti-inflammatory effects of antidepressants through suppression of the interferon-\u03b3\/Interleukin-10 production ratio. J Clin Psychopharmacol. 2001;21:199\u2013206.","journal-title":"J Clin Psychopharmacol"},{"key":"3532_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-39048-x","volume":"9","author":"J Kisuya","year":"2019","unstructured":"Kisuya J, Chemtai A, Raballah E, Keter A, Ouma C. The diagnostic accuracy of Th1 (IFN-\u03b3, TNF-\u03b1, and IL-2) and Th2 (IL-4, IL-6 and IL-10) cytokines response in AFB microscopy smear negative PTB- HIV co-infected patients. Sci Rep. 2019;9:2966.","journal-title":"Sci Rep"},{"key":"3532_CR75","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41420-022-01147-6","volume":"8","author":"CW Beckett","year":"2022","unstructured":"Beckett CW, Niklison-Chirou MV. The role of immunomodulators in treatment-resistant depression: case studies. Cell Death Discov. 2022;8:367.","journal-title":"Cell Death Discov"},{"key":"3532_CR76","doi-asserted-by":"publisher","first-page":"21362","DOI":"10.1074\/jbc.M600504200","volume":"281","author":"H Takeuchi","year":"2006","unstructured":"Takeuchi H, Jin S, Wang J, Zhang G, Kawanokuchi J, Kuno R, et al. Tumor necrosis factor-\u03b1 induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J Biol Chem. 2006;281:21362\u20138.","journal-title":"J Biol Chem"},{"key":"3532_CR77","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1096\/fj.07-099499","volume":"22","author":"T Mizuno","year":"2008","unstructured":"Mizuno T, Zhang G, Takeuchi H, Kawanokuchi J, Wang J, Sonobe Y, et al. Interferon\u2010\u03b3 directly induces neurotoxicity through a neuron specific, calcium\u2010permeable complex of IFN\u2010\u03b3 receptor and AMPA GluRl receptor. FASEB J. 2008;22:1797\u2013806.","journal-title":"FASEB J"},{"key":"3532_CR78","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3988\/jcn.2021.17.4.503","volume":"17","author":"K-M Han","year":"2021","unstructured":"Han K-M, Ham B-J. How inflammation affects the brain in depression: a review of functional and structural MRI studies. J Clin Neurol. 2021;17:503.","journal-title":"J Clin Neurol"},{"key":"3532_CR79","doi-asserted-by":"publisher","first-page":"1130989","DOI":"10.3389\/fpsyt.2023.1130989","volume":"14","author":"S Hassamal","year":"2023","unstructured":"Hassamal S. Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories. Front Psychiatry. 2023;14:1130989. https:\/\/doi.org\/10.3389\/fpsyt.2023.1130989.","journal-title":"Front Psychiatry"},{"key":"3532_CR80","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1089\/scd.2022.0004","volume":"31","author":"M Espinosa Gonzalez","year":"2022","unstructured":"Espinosa Gonzalez M, Volk-Draper L, Bhattarai N, Wilber A, Ran S. Th2 cytokines IL-4, IL-13, and IL-10 promote differentiation of pro-lymphatic progenitors derived from bone marrow myeloid precursors. Stem Cells Dev. 2022;31:322\u201333.","journal-title":"Stem Cells Dev"},{"key":"3532_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0763-8","volume":"13","author":"D Lobo-Silva","year":"2016","unstructured":"Lobo-Silva D, Carriche GM, Castro AG, Roque S, Saraiva M. Balancing the immune response in the brain: IL-10 and its regulation. J Neuroinflammation. 2016;13:297.","journal-title":"J Neuroinflammation"},{"key":"3532_CR82","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.psychres.2010.10.029","volume":"188","author":"Y Chen","year":"2011","unstructured":"Chen Y, Jiang T, Chen P, Ouyang J, Xu G, Zeng Z, et al. Emerging tendency towards autoimmune process in major depressive patients: a novel insight from Th17 cells. Psychiatry Res. 2011;188:224\u201330.","journal-title":"Psychiatry Res"},{"key":"3532_CR83","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.bbi.2020.02.005","volume":"87","author":"C Schiweck","year":"2020","unstructured":"Schiweck C, Valles-Colomer M, Arolt V, M\u00fcller N, Raes J, Wijkhuijs A, et al. Depression and suicidality: a link to premature T helper cell aging and increased Th17 cells. Brain Behav Immun. 2020;87:603\u20139.","journal-title":"Brain Behav Immun"},{"key":"3532_CR84","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jneuroim.2011.06.009","volume":"238","author":"TB Ferreira","year":"2011","unstructured":"Ferreira TB, Kasahara TM, Barros PO, Vieira MMM, Bittencourt VCB, Hygino J, et al. Dopamine up-regulates Th17 phenotype from individuals with generalized anxiety disorder. J Neuroimmunol. 2011;238:58\u201366.","journal-title":"J Neuroimmunol"},{"key":"3532_CR85","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jneuroim.2010.07.018","volume":"229","author":"MMM Vieira","year":"2010","unstructured":"Vieira MMM, Ferreira TB, Pacheco PAF, Barros PO, Almeida CRM, Ara\u00fajo-Lima CF, et al. Enhanced Th17 phenotype in individuals with generalized anxiety disorder. J Neuroimmunol. 2010;229:212\u20138.","journal-title":"J Neuroimmunol"},{"key":"3532_CR86","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1001\/archdermatol.2010.186","volume":"146","author":"C Olivier","year":"2010","unstructured":"Olivier C, Robert PD, Daihung D, Urb\u00e0 G, Catalin MP, Hywel W, et al. The risk of depression, anxiety, and suicidality in patients with psoriasis. Arch Dermatol. 2010;146:891\u20135. https:\/\/doi.org\/10.1001\/archdermatol.2010.186.","journal-title":"Arch Dermatol"},{"key":"3532_CR87","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1080\/09540261.2017.1322555","volume":"29","author":"SB Patten","year":"2017","unstructured":"Patten SB, Marrie RA, Carta MG. Depression in multiple sclerosis. Int Rev Psychiatry. 2017;29:463\u201372.","journal-title":"Int Rev Psychiatry"},{"key":"3532_CR88","doi-asserted-by":"publisher","first-page":"137","DOI":"10.15412\/J.BCN.03070207","volume":"7","author":"M Davami","year":"2016","unstructured":"Davami M, Baharlou R, Ahmadi Vasmehjani A, Ghanizadeh A, Keshtkar M, Dezhkam I, et al. Elevated IL-17 and TGF-\u03b2 serum levels: a positive correlation between T-helper 17 cell-related pro-inflammatory responses with major depressive disorder. Basic Clin Neurosci. 2016;7:137\u201342. https:\/\/doi.org\/10.15412\/J.BCN.03070207.","journal-title":"Basic Clin Neurosci"},{"key":"3532_CR89","doi-asserted-by":"publisher","first-page":"294","DOI":"10.4306\/pi.2013.10.3.294","volume":"10","author":"J-W Kim","year":"2013","unstructured":"Kim J-W, Kim Y-K, Hwang J-A, Yoon H-K, Ko Y-H, Han C, et al. Plasma levels of IL-23 and IL-17 before and after antidepressant treatment in patients with major depressive disorder. Psychiatry Investig. 2013;10:294\u20139.","journal-title":"Psychiatry Investig"},{"key":"3532_CR90","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1756-185X.2011.01673.x","volume":"15","author":"Y Liu","year":"2012","unstructured":"Liu Y, Ho RC, Mak A. The role of interleukin (IL)\u201017 in anxiety and depression of patients with rheumatoid arthritis. Int J Rheum Dis. 2012;15:183\u20137.","journal-title":"Int J Rheum Dis"},{"key":"3532_CR91","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1159\/000479163","volume":"86","author":"CEM Griffiths","year":"2017","unstructured":"Griffiths CEM, Fava M, Miller AH, Russell J, Ball SG, Xu W, et al. Impact of ixekizumab treatment on depressive symptoms and systemic inflammation in patients with moderate-to-severe psoriasis: an integrated analysis of three phase 3 clinical studies. Psychother Psychosom. 2017;86:260\u20137.","journal-title":"Psychother Psychosom"},{"key":"3532_CR92","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.bbi.2017.07.005","volume":"66","author":"MK Jha","year":"2017","unstructured":"Jha MK, Minhajuddin A, Gadad BS, Greer TL, Mayes TL, Trivedi MH. Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: novel T cell biomarker for antidepressant medication selection. Brain Behav Immun. 2017;66:103\u201310.","journal-title":"Brain Behav Immun"},{"key":"3532_CR93","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cyto.2017.05.018","volume":"97","author":"A Nadeem","year":"2017","unstructured":"Nadeem A, Ahmad SF, Al-Harbi NO, Fardan AS, El-Sherbeeny AM, Ibrahim KE, et al. IL-17A causes depression-like symptoms via NF\u03baB and p38MAPK signaling pathways in mice: implications for psoriasis associated depression. Cytokine. 2017;97:14\u201324.","journal-title":"Cytokine"},{"key":"3532_CR94","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/nu10101351","volume":"10","author":"M Gu","year":"2018","unstructured":"Gu M, Li Y, Tang H, Zhang C, Li W, Zhang Y, et al. Endogenous omega (n)-3 fatty acids in Fat-1 mice attenuated depression-like behavior, imbalance between microglial M1 and M2 phenotypes, and dysfunction of neurotrophins induced by lipopolysaccharide administration. Nutrients. 2018;10:1351. https:\/\/doi.org\/10.3390\/nu10101351.","journal-title":"Nutrients"},{"key":"3532_CR95","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.bbi.2018.02.003","volume":"69","author":"Y Cheng","year":"2018","unstructured":"Cheng Y, Desse S, Martinez A, Worthen RJ, Jope RS, Beurel E. TNF\u03b1 disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice. Brain Behav Immun. 2018;69:556\u201367.","journal-title":"Brain Behav Immun"},{"key":"3532_CR96","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bbi.2017.08.001","volume":"69","author":"E Beurel","year":"2018","unstructured":"Beurel E, Lowell JA. Th17 cells in depression. Brain Behav Immun. 2018;69:28\u201334.","journal-title":"Brain Behav Immun"},{"key":"3532_CR97","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.3390\/ijms20143512","volume":"20","author":"O Ambr\u00e9e","year":"2019","unstructured":"Ambr\u00e9e O, Ruland C, Zwanzger P, Klotz L, Baune BT, Arolt V, et al. Social defeat modulates T helper cell percentages in stress susceptible and resilient mice. Int J Mol Sci. 2019;20:3512.","journal-title":"Int J Mol Sci"},{"key":"3532_CR98","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1017\/S1092852900025475","volume":"9","author":"CB Nemeroff","year":"2004","unstructured":"Nemeroff CB, Owens MJ. Pharmacologic differences among the SSRIs: focus on monoamine transporters and the HPA axis. CNS Spectr. 2004;9:23\u201331.","journal-title":"CNS Spectr"},{"key":"3532_CR99","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.euroneuro.2008.08.001","volume":"18","author":"ME Hern\u00e1ndez","year":"2008","unstructured":"Hern\u00e1ndez ME, Mendieta D, Mart\u00ednez-Fong D, Lor\u00eda F, Moreno J, Estrada I, et al. Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder. Eur Neuropsychopharmacol. 2008;18:917\u201324.","journal-title":"Eur Neuropsychopharmacol"},{"key":"3532_CR100","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.psychres.2004.01.014","volume":"134","author":"M Kubera","year":"2005","unstructured":"Kubera M, Maes M, Kenis G, Kim YK, Laso\u0144 W. Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor \u03b1 and interleukin-6. Psychiatry Res. 2005;134:251\u20138.","journal-title":"Psychiatry Res"},{"key":"3532_CR101","doi-asserted-by":"publisher","first-page":"76396","DOI":"10.1155\/2007\/76396","volume":"2007","author":"L Sutcigil","year":"2007","unstructured":"Sutcigil L, Oktenli C, Musabak U, Bozkurt A, Cansever A, Uzun O, et al. Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy. Clin Dev Immunol. 2007;2007:76396. https:\/\/doi.org\/10.1155\/2007\/76396.","journal-title":"Clin Dev Immunol"},{"key":"3532_CR102","first-page":"977","volume":"19","author":"L Rafiee","year":"2016","unstructured":"Rafiee L, Hajhashemi V, Javanmard SH. Fluvoxamine inhibits some inflammatory genes expression in LPS\/stimulated human endothelial cells, U937 macrophages, and carrageenan-induced paw edema in rat. Iran J Basic Med Sci. 2016;19:977\u201384.","journal-title":"Iran J Basic Med Sci"},{"key":"3532_CR103","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.euroneuro.2005.11.011","volume":"16","author":"M Diamond","year":"2006","unstructured":"Diamond M, Kelly JP, Connor TJ. Antidepressants suppress production of the Th1 cytokine interferon-\u03b3, independent of monoamine transporter blockade. Eur Neuropsychopharmacol. 2006;16:481\u201390.","journal-title":"Eur Neuropsychopharmacol"},{"key":"3532_CR104","doi-asserted-by":"publisher","first-page":"5710","DOI":"10.2174\/0929867328666211115124149","volume":"29","author":"A Della Vecchia","year":"2022","unstructured":"Della Vecchia A, Arone A, Piccinni A, Mucci F, Marazziti D. GABA system in depression: impact on pathophysiology and psychopharmacology. Curr Med Chem. 2022;29:5710\u201330.","journal-title":"Curr Med Chem"},{"key":"3532_CR105","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neubiorev.2019.07.024","volume":"105","author":"CE Page","year":"2019","unstructured":"Page CE, Coutellier L. Prefrontal excitatory\/inhibitory balance in stress and emotional disorders: evidence for over-inhibition. Neurosci Biobehav Rev. 2019;105:39\u201351.","journal-title":"Neurosci Biobehav Rev"},{"key":"3532_CR106","doi-asserted-by":"publisher","first-page":"113434","DOI":"10.1016\/j.expneurol.2020.113434","volume":"333","author":"N Pozdnyakova","year":"2020","unstructured":"Pozdnyakova N, Krisanova N, Dudarenko M, Vavers E, Zvejniece L, Dambrova M, et al. Inhibition of sigma-1 receptors substantially modulates GABA and glutamate transport in presynaptic nerve terminals. Exp Neurol. 2020;333:113434.","journal-title":"Exp Neurol"},{"key":"3532_CR107","doi-asserted-by":"publisher","first-page":"eaau5266","DOI":"10.1126\/scitranslmed.aau5266","volume":"11","author":"DA Rosen","year":"2019","unstructured":"Rosen DA, Seki SM, Fern\u00e1ndez-Casta\u00f1eda A, Beiter RM, Eccles JD, Woodfolk JA, et al. Modulation of the sigma-1 receptor\u2013IRE1 pathway is beneficial in preclinical models of inflammation and sepsis. Sci Transl Med. 2019;11:eaau5266. https:\/\/doi.org\/10.1126\/scitranslmed.aau5266.","journal-title":"Sci Transl Med"},{"key":"3532_CR108","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1038\/s41401-021-00807-0","volume":"43","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Ye L, Li T, Guo F, Guo F, Li Y, et al. New monoamine antidepressant, hypidone hydrochloride (YL-0919), enhances the excitability of medial prefrontal cortex in mice via a neural disinhibition mechanism. Acta Pharmacol Sin. 2022;43:1699\u2013709.","journal-title":"Acta Pharmacol Sin"},{"key":"3532_CR109","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ejphar.2014.01.064","volume":"727","author":"T Ishima","year":"2014","unstructured":"Ishima T, Fujita Y, Hashimoto K. Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells. Eur J Pharmacol. 2014;727:167\u201373.","journal-title":"Eur J Pharmacol"},{"key":"3532_CR110","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1677\/joe.0.1820011","volume":"182","author":"M Robichaud","year":"2004","unstructured":"Robichaud M, Debonnel G. Modulation of the firing activity of female dorsal raphe nucleus serotonergic neurons by neuroactive steroids. J Endocrinol. 2004;182:11\u201321.","journal-title":"J Endocrinol"},{"key":"3532_CR111","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.neubiorev.2021.10.037","volume":"132","author":"K Sa\u0142aciak","year":"2022","unstructured":"Sa\u0142aciak K, Pytka K. Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders. Neurosci Biobehav Rev. 2022;132:1114\u201336.","journal-title":"Neurosci Biobehav Rev"},{"key":"3532_CR112","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1016\/S0028-3908(00)00018-6","volume":"39","author":"J-C B\u00e9\u0131\u0308que","year":"2000","unstructured":"B\u00e9\u0131\u0308que J-C, de Montigny C, Blier P, Debonnel G. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat. Neuropharmacology. 2000;39:1813\u201322.","journal-title":"Neuropharmacology"},{"key":"3532_CR113","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1017\/S1461145705006413","volume":"10","author":"G Debonnel","year":"2007","unstructured":"Debonnel G, Saint-Andr\u00e9 \u00c9, H\u00e9bert C, De Montigny C, Lavoie N, Blier P. Differential physiological effects of a low dose and high doses of venlafaxine in major depression. Int J Neuropsychopharmacol. 2007;10:51\u201361.","journal-title":"Int J Neuropsychopharmacol"},{"key":"3532_CR114","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1017\/S1461145707007729","volume":"11","author":"P Vollmar","year":"2008","unstructured":"Vollmar P, Haghikia A, Dermietzel R, Faustmann PM. Venlafaxine exhibits an anti-inflammatory effect in an inflammatory co-culture model. Int J Neuropsychopharmacol. 2008;11:111\u20137. https:\/\/doi.org\/10.1017\/S1461145707007729.","journal-title":"Int J Neuropsychopharmacol"},{"key":"3532_CR115","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1017\/S1461145708009425","volume":"12","author":"P Vollmar","year":"2009","unstructured":"Vollmar P, Nessler S, Kalluri SR, Hartung H-P, Hemmer B. The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokines. Int J Neuropsychopharmacol. 2009;12:525.","journal-title":"Int J Neuropsychopharmacol"},{"key":"3532_CR116","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.pnpbp.2004.05.026","volume":"28","author":"RW Invernizzi","year":"2004","unstructured":"Invernizzi RW, Garattini S. Role of presynaptic \u03b12-adrenoceptors in antidepressant action: recent findings from microdialysis studies. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:819\u201327.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3532_CR117","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2147\/NDT.S16382","volume":"7","author":"M Fornaro","year":"2011","unstructured":"Fornaro M, Martino M, Battaglia F, Colicchio S, Perugi G. Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60\u2009mg\/day: a preliminary observation. Neuropsychiatr Dis Treat. 2011;7:51\u20136.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"3532_CR118","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/amhs.amhs_7_18","volume":"6","author":"O Fasipe","year":"2018","unstructured":"Fasipe O. Neuropharmacological classification of antidepressant agents based on their mechanisms of action. Arch Med Health Sci. 2018;6:81.","journal-title":"Arch Med Health Sci"},{"key":"3532_CR119","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1177\/0269881105051526","volume":"19","author":"Y Odagaki","year":"2005","unstructured":"Odagaki Y, Toyoshima R, Yamauchi T. Trazodone and its active metabolite m-chlorophenylpiperazine as partial agonists at 5-HT1A receptors assessed by [35S]GTP\u03b3S binding. J Psychopharmacol. 2005;19:235\u201341.","journal-title":"J Psychopharmacol"},{"key":"3532_CR120","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.cellsig.2015.04.006","volume":"27","author":"S Daniele","year":"2015","unstructured":"Daniele S, Da Pozzo E, Zappelli E, Martini C. Trazodone treatment protects neuronal-like cells from inflammatory insult by inhibiting NF-\u03baB, p38 and JNK. Cell Signal. 2015;27:1609\u201329.","journal-title":"Cell Signal"},{"key":"3532_CR121","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2174\/157015912800604542","volume":"10","author":"M Martino","year":"2012","unstructured":"Martino M, Rocchi G, Escelsior A, Fornaro M. Immunomodulation mechanism of antidepressants: interactions between serotonin\/norepinephrine balance and Th1\/Th2 balance. Curr Neuropharmacol. 2012;10:97\u2013123.","journal-title":"Curr Neuropharmacol"},{"key":"3532_CR122","doi-asserted-by":"publisher","first-page":"S14611457020031","DOI":"10.1017\/S1461145702003164","volume":"5","author":"G Kenis","year":"2002","unstructured":"Kenis G, Maes M. Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol. 2002;5:S1461145702003164.","journal-title":"Int J Neuropsychopharmacol"},{"key":"3532_CR123","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.eurpsy.2008.04.002","volume":"23","author":"L San","year":"2008","unstructured":"San L, Arranz B. Agomelatine: A novel mechanism of antidepressant action involving the melatonergic and the serotonergic system. Eur Psychiatry. 2008;23:396\u2013402.","journal-title":"Eur Psychiatry"},{"key":"3532_CR124","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1017\/S146114570500547X","volume":"9","author":"E Obuchowicz","year":"2005","unstructured":"Obuchowicz E, Kowalski J, Labuzek K, Krysiak R, Pendzich J, Herman ZS. Amitriptyline and nortriptyline inhibit interleukin-1 release by rat mixed glial and microglial cell cultures. Int J Neuropsychopharmacol. 2005;9:27.","journal-title":"Int J Neuropsychopharmacol"},{"key":"3532_CR125","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.intimp.2003.11.006","volume":"4","author":"M Kubera","year":"2004","unstructured":"Kubera M, Kenis G, Bosmans E, Kajta M, Basta-Kaim A, Scharpe S, et al. Stimulatory effect of antidepressants on the production of IL-6. Int Immunopharmacol. 2004;4:185\u201392.","journal-title":"Int Immunopharmacol"},{"key":"3532_CR126","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1254\/jphs.FP0061255","volume":"104","author":"YY Huang","year":"2007","unstructured":"Huang YY, Peng CH, Yang YP, Wu CC, Hsu WM, Wang HJ, et al. Desipramine activated Bcl-2 expression and inhibited lipopolysaccharide- induced apoptosis in hippocampus-derived adult neural stem cells. J Pharmacol Sci. 2007;104:61\u201372.","journal-title":"J Pharmacol Sci"},{"key":"3532_CR127","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pain.2006.03.018","volume":"124","author":"YH Tai","year":"2006","unstructured":"Tai YH, Wang YH, Wang JJ, Tao PL, Tung CS, Wong CS. Amitriptyline suppresses neuroinflammation and up-regulates glutamate transporters in morphine-tolerant rats. Pain. 2006;124:77\u201386.","journal-title":"Pain"},{"key":"3532_CR128","first-page":"540","volume":"57","author":"B Budziszewska","year":"2005","unstructured":"Budziszewska B, Basta-Kaim A, Kubera M, Jaworska L, Le\u015bkiewicz M, Tetich M, et al. Effect of lipopolysaccharide and antidepressant drugs on glucocorticoid receptor-mediated gene transcription. Pharmacol Rep. 2005;57:540\u20134.","journal-title":"Pharmacol Rep"},{"key":"3532_CR129","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0899-9007(02)00921-8","volume":"19","author":"W Wang","year":"2003","unstructured":"Wang W, Danielsson A, Svanberg E, Lundholm K. Lack of effects by tricyclic antidepressant and serotonin inhibitors on anorexia in MCG 101 tumor-bearing mice with eicosanoid-related cachexia. Nutrition. 2003;19:47\u201353.","journal-title":"Nutrition"},{"key":"3532_CR130","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.4088\/JCP.11096tx4c","volume":"73","author":"ME Thase","year":"2012","unstructured":"Thase ME. MAOIs and depression treatment guidelines. J Clin Psychiatry. 2012;73:e24.","journal-title":"J Clin Psychiatry"},{"key":"3532_CR131","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0165-0327(99)00076-2","volume":"58","author":"A Lin","year":"2000","unstructured":"Lin A, Song C, Kenis G, Bosmans E, De Jongh R, Scharp\u00e9 S, et al. The in vitro immunosuppressive effects of moclobemide in healthy volunteers. J Affect Disord. 2000;58:69\u201374.","journal-title":"J Affect Disord"},{"key":"3532_CR132","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.2353\/ajpath.2009.090108","volume":"175","author":"D Ekuni","year":"2009","unstructured":"Ekuni D, Firth JD, Nayer T, Tomofuji T, Sanbe T, Irie K, et al. Lipopolysaccharide-induced epithelial monoamine oxidase mediates alveolar bone loss in a rat chronic wound model. Am J Pathol. 2009;175:1398\u2013409.","journal-title":"Am J Pathol"},{"key":"3532_CR133","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.bbi.2010.02.005","volume":"24","author":"EN McNamee","year":"2010","unstructured":"McNamee EN, Ryan KM, Griffin \u00c9W, Gonz\u00e1lez-Reyes RE, Ryan KJ, Harkin A, et al. Noradrenaline acting at central \u03b2-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: implications for neurodegeneration. Brain Behav Immun. 2010;24:660\u201371.","journal-title":"Brain Behav Immun"},{"key":"3532_CR134","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.expneurol.2007.03.022","volume":"206","author":"S Hashioka","year":"2007","unstructured":"Hashioka S, Klegeris A, Monji A, Kato T, Sawada M, McGeer PL, et al. Antidepressants inhibit interferon-\u03b3-induced microglial production of IL-6 and nitric oxide. Exp Neurol. 2007;206:33\u201342.","journal-title":"Exp Neurol"},{"key":"3532_CR135","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.intimp.2005.12.007","volume":"6","author":"D Brustolim","year":"2006","unstructured":"Brustolim D, Ribeiro-dos-Santos R, Kast RE, Altschuler EL, Soares MBP. A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice. Int Immunopharmacol. 2006;6:903\u20137.","journal-title":"Int Immunopharmacol"},{"key":"3532_CR136","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4088\/PCC.v06n0403","volume":"6","author":"SM Stahl","year":"2004","unstructured":"Stahl SM, Pradko J, Haight BR, Modell JG, Rockett CB, Learned-Coughlin S. A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Prim Care Companion CNS Disord. 2004;6:159\u201366. https:\/\/doi.org\/10.4088\/PCC.v06n0403.","journal-title":"Prim Care Companion CNS Disord"},{"key":"3532_CR137","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/j.biocel.2009.05.015","volume":"41","author":"HR Arias","year":"2009","unstructured":"Arias HR. Is the inhibition of nicotinic acetylcholine receptors by bupropion involved in its clinical actions? Int J Biochem Cell Biol. 2009;41:2098\u2013108.","journal-title":"Int J Biochem Cell Biol"},{"key":"3532_CR138","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.1021\/bi802206k","volume":"48","author":"HR Arias","year":"2009","unstructured":"Arias HR, Gumilar F, Rosenberg A, Targowska-Duda KM, Feuerbach D, Jozwiak K, et al. Interaction of bupropion with muscle-type nicotinic acetylcholine receptors in different conformational states. Biochemistry. 2009;48:4506\u201318.","journal-title":"Biochemistry"},{"key":"3532_CR139","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4103\/jmedsci.jmedsci_124_23","volume":"44","author":"C-C Huang","year":"2024","unstructured":"Huang C-C, Chu H-T, Lin Y-K, Tsai C-K, Liang C-S, Yeh T-C. Bupropion associated immunomodulatory effects on peripheral cytokines in male with major depressive disorder. J Med Sci. 2024;44:66\u201373.","journal-title":"J Med Sci"},{"key":"3532_CR140","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/mp.2017.190","volume":"23","author":"M Kokkinou","year":"2018","unstructured":"Kokkinou M, Ashok AH, Howes OD. The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders. Mol Psychiatry. 2018;23:59\u201369.","journal-title":"Mol Psychiatry"},{"key":"3532_CR141","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1177\/0269881108091077","volume":"23","author":"T Eller","year":"2009","unstructured":"Eller T, Vasar V, Shlik J, Maron E. Effects of bupropion augmentation on pro-inflammatory cytokines in escitalopram-resistant patients with major depressive disorder. J Psychopharmacol. 2009;23:854\u20138.","journal-title":"J Psychopharmacol"},{"key":"3532_CR142","doi-asserted-by":"publisher","first-page":"e632","DOI":"10.1038\/tp.2015.136","volume":"5","author":"C Yang","year":"2015","unstructured":"Yang C, Shirayama Y, Zhang J, Ren Q, Yao W, Ma M, et al. R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects. Transl Psychiatry. 2015;5:e632.","journal-title":"Transl Psychiatry"},{"key":"3532_CR143","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1124\/jpet.116.239228","volume":"361","author":"K Fukumoto","year":"2017","unstructured":"Fukumoto K, Toki H, Iijima M, Hashihayata T, Yamaguchi J, Hashimoto K, et al. Antidepressant potential of (R)-ketamine in rodent models: comparison with (S)-ketamine. J Pharmacol Exp Ther. 2017;361:9\u201316.","journal-title":"J Pharmacol Exp Ther"},{"key":"3532_CR144","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.pbb.2019.04.008","volume":"181","author":"L Chang","year":"2019","unstructured":"Chang L, Zhang K, Pu Y, Qu Y, Wang S, Xiong Z, et al. Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine. Pharmacol Biochem Behav. 2019;181:53\u201359.","journal-title":"Pharmacol Biochem Behav"},{"key":"3532_CR145","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/0269881120959644","volume":"35","author":"LA Jelen","year":"2021","unstructured":"Jelen LA, Young AH, Stone JM. Ketamine: a tale of two enantiomers. J Psychopharmacol. 2021;35:109\u201323.","journal-title":"J Psychopharmacol"},{"key":"3532_CR146","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/bja\/aem218","volume":"99","author":"B Beilin","year":"2007","unstructured":"Beilin B, Rusabrov Y, Shapira Y, Roytblat L, Greemberg L, Yardeni IZ, et al. Low-dose ketamine affects immune responses in humans during the early postoperative period. Br J Anaesth. 2007;99:522\u20137.","journal-title":"Br J Anaesth"},{"key":"3532_CR147","first-page":"47","volume":"62","author":"S Loix","year":"2011","unstructured":"Loix S, De Kock M, Henin P. The anti-inflammatory effects of ketamine: state of the art. Acta Anaesthesiol Belg. 2011;62:47\u201358.","journal-title":"Acta Anaesthesiol Belg"},{"key":"3532_CR148","doi-asserted-by":"publisher","first-page":"100383","DOI":"10.1016\/j.bbih.2021.100383","volume":"18","author":"N Nikkheslat","year":"2021","unstructured":"Nikkheslat N. Targeting inflammation in depression: ketamine as an anti-inflammatory antidepressant in psychiatric emergency. Brain Behav Immun Health. 2021;18:100383.","journal-title":"Brain Behav Immun Health"},{"key":"3532_CR149","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1176\/appi.ajp.2020.20060947","volume":"178","author":"MC Pitharouli","year":"2021","unstructured":"Pitharouli MC, Hagenaars SP, Glanville KP, Coleman JRI, Hotopf M, Lewis CM, et al. Elevated C-reactive protein in patients with depression, independent of genetic, health, and psychosocial factors: results from the UK biobank. Am J Psychiatry. 2021;178:522\u20139.","journal-title":"Am J Psychiatry"},{"key":"3532_CR150","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1177\/02698811211026426","volume":"35","author":"E Kopra","year":"2021","unstructured":"Kopra E, Mondelli V, Pariante C, Nikkheslat N. Ketamine\u2019s effect on inflammation and kynurenine pathway in depression: a systematic review. J Psychopharmacol. 2021;35:934\u201345.","journal-title":"J Psychopharmacol"},{"key":"3532_CR151","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.bbi.2018.09.007","volume":"74","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Zheng W, Liu W, Wang C, Zhan Y, Li H, et al. Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression. Brain Behav Immun. 2018;74:205\u201312.","journal-title":"Brain Behav Immun"},{"key":"3532_CR152","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.cyto.2011.06.022","volume":"56","author":"M Gao","year":"2011","unstructured":"Gao M, Jin W, Qian Y, Ji L, Feng G, Sun J. Effect of N-methyl-D-aspartate receptor antagonist on T helper cell differentiation induced by phorbol-myristate-acetate and ionomycin. Cytokine. 2011;56:458\u201365.","journal-title":"Cytokine"},{"key":"3532_CR153","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.brainresrev.2009.06.003","volume":"61","author":"SI Rapoport","year":"2009","unstructured":"Rapoport SI, Basselin M, Kim H-W, Rao JS. Bipolar disorder and mechanisms of action of mood stabilizers. Brain Res Rev. 2009;61:185\u2013209.","journal-title":"Brain Res Rev"},{"key":"3532_CR154","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1124\/pr.111.005512","volume":"65","author":"C-T Chiu","year":"2013","unstructured":"Chiu C-T, Wang Z, Hunsberger JG, Chuang D-M. Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder. Pharmacol Rev. 2013;65:105\u201342.","journal-title":"Pharmacol Rev"},{"key":"3532_CR155","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.biopsych.2013.01.007","volume":"74","author":"A Modabbernia","year":"2013","unstructured":"Modabbernia A, Taslimi S, Brietzke E, Ashrafi M. Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol Psychiatry. 2013;74:15\u201325.","journal-title":"Biol Psychiatry"},{"key":"3532_CR156","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jad.2020.11.063","volume":"281","author":"R Queissner","year":"2021","unstructured":"Queissner R, Lenger M, Birner A, Dalkner N, Fellendorf F, Bengesser S, et al. The association between anti-inflammatory effects of long-term lithium treatment and illness course in bipolar disorder. J Affect Disord. 2021;281:228\u201334.","journal-title":"J Affect Disord"},{"key":"3532_CR157","first-page":"2775","volume":"31","author":"S Shi","year":"2018","unstructured":"Shi S, Li L, Song L, Wang X. Effect of lamotrigine on cognitive function and serum inflammatory factors in patients with depression of recurrent bipolar disorder. Pak J Pharm Sci. 2018;31:2775\u20138.","journal-title":"Pak J Pharm Sci"},{"key":"3532_CR158","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jad.2004.01.007","volume":"82","author":"F Boufidou","year":"2004","unstructured":"Boufidou F, Nikolaou C, Alevizos B, Liappas IA, Christodoulou GN. Cytokine production in bipolar affective disorder patients under lithium treatment. J Affect Disord. 2004;82:309\u201313.","journal-title":"J Affect Disord"},{"key":"3532_CR159","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/glia.24123","volume":"70","author":"R G\u00f6ttert","year":"2022","unstructured":"G\u00f6ttert R, Fidzinski P, Kraus L, Schneider UC, Holtkamp M, Endres M, et al. Lithium inhibits tryptophan catabolism via the inflammation\u2010induced kynurenine pathway in human microglia. Glia. 2022;70:558\u201371.","journal-title":"Glia"},{"key":"3532_CR160","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1158\/1078-0432.CCR-06-2903","volume":"13","author":"A Nencioni","year":"2007","unstructured":"Nencioni A, Beck J, Werth D, Gr\u00fcnebach F, Patrone F, Ballestrero A, et al. Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity. Clin Cancer Res. 2007;13:3933\u201341.","journal-title":"Clin Cancer Res"},{"key":"3532_CR161","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1002\/jcp.25604","volume":"232","author":"S Leu","year":"2017","unstructured":"Leu S, Yang Y, Liu H, Cheng C, Wu Y, Huang M, et al. Valproic acid and lithium meditate anti\u2010inflammatory effects by differentially modulating dendritic cell differentiation and function. J Cell Physiol. 2017;232:1176\u201386.","journal-title":"J Cell Physiol"},{"key":"3532_CR162","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3389\/fpsyt.2018.00451","volume":"9","author":"Y Liu","year":"2018","unstructured":"Liu Y, Tang X. Depressive syndromes in autoimmune disorders of the nervous system: prevalence, etiology, and influence. Front Psychiatry. 2018;9:451. https:\/\/doi.org\/10.3389\/fpsyt.2018.00451.","journal-title":"Front Psychiatry"},{"key":"3532_CR163","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.iac.2009.02.008","volume":"29","author":"SM Gold","year":"2009","unstructured":"Gold SM, Irwin MR. Depression and immunity: inflammation and depressive symptoms in multiple sclerosis. Immunol Allergy Clin North Am. 2009;29:309\u201320.","journal-title":"Immunol Allergy Clin North Am"},{"key":"3532_CR164","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.bbi.2004.10.003","volume":"19","author":"CE Wright","year":"2005","unstructured":"Wright CE, Strike PC, Brydon L, Steptoe A. Acute inflammation and negative mood: mediation by cytokine activation. Brain Behav Immun. 2005;19:345\u201350.","journal-title":"Brain Behav Immun"},{"key":"3532_CR165","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1212\/WNL.59.5.744","volume":"59","author":"SB Patten","year":"2002","unstructured":"Patten SB, Metz LM. Interferon \u03b21a and depression in secondary progressive MS: data from the SPECTRIMS trial. Neurology. 2002;59:744\u20136.","journal-title":"Neurology"},{"key":"3532_CR166","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000077739","volume":"73","author":"SB Patten","year":"2004","unstructured":"Patten SB, Barbui C. Drug-induced depression: a systematic review to inform clinical practice. Psychother Psychosom. 2004;73:207\u201315.","journal-title":"Psychother Psychosom"},{"key":"3532_CR167","doi-asserted-by":"publisher","first-page":"e000313","DOI":"10.1136\/bmjopen-2011-000313","volume":"1","author":"Y Suzuki","year":"2011","unstructured":"Suzuki Y, Utsugisawa K, Suzuki S, Nagane Y, Masuda M, Kabasawa C, et al. Factors associated with depressive state in patients with myasthenia gravis: a multicentre cross-sectional study. BMJ Open. 2011;1:e000313.","journal-title":"BMJ Open"},{"key":"3532_CR168","doi-asserted-by":"publisher","first-page":"370","DOI":"10.6061\/clinics\/2016(07)03","volume":"71","author":"AM Mour\u00e3o","year":"2016","unstructured":"Mour\u00e3o AM, Gomez RS, Barbosa LSM, da Silva Freitas D, Comini-Frota ER, Kummer A, et al. Determinants of quality of life in Brazilian patients with myasthenia gravis. Clinics. 2016;71:370\u20134.","journal-title":"Clinics"},{"key":"3532_CR169","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0022-3999(00)00187-2","volume":"49","author":"SB Patten","year":"2000","unstructured":"Patten SB. Exogenous corticosteroids and major depression in the general population. J Psychosom Res. 2000;49:447\u20139.","journal-title":"J Psychosom Res"},{"key":"3532_CR170","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.3390\/ijms23031616","volume":"23","author":"L Orsolini","year":"2022","unstructured":"Orsolini L, Pompili S, Tempia Valenta S, Salvi V, Volpe U. C-reactive protein as a biomarker for major depressive disorder? Int J Mol Sci. 2022;23:1616.","journal-title":"Int J Mol Sci"},{"key":"3532_CR171","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bbi.2009.08.005","volume":"24","author":"KA Matthews","year":"2010","unstructured":"Matthews KA, Schott LL, Bromberger JT, Cyranowski JM, Everson-Rose SA, Sowers M. Are there bi-directional associations between depressive symptoms and C-reactive protein in mid-life women? Brain Behav Immun. 2010;24:96\u2013101.","journal-title":"Brain Behav Immun"},{"key":"3532_CR172","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/S0140-6736(07)60784-3","volume":"370","author":"JS Smolen","year":"2007","unstructured":"Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P. New therapies for treatment of rheumatoid arthritis. Lancet. 2007;370:1861\u201374.","journal-title":"Lancet"},{"key":"3532_CR173","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1136\/eb-2016-102417","volume":"19","author":"ME Benros","year":"2016","unstructured":"Benros ME. Autoimmune diseases can be associated with depression. Evid Based Ment Health. 2016;19:e27.","journal-title":"Evid Based Ment Health"},{"key":"3532_CR174","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1001\/jamapsychiatry.2013.1111","volume":"70","author":"ME Benros","year":"2013","unstructured":"Benros ME, Waltoft BL, Nordentoft M, \u00d8stergaard SD, Eaton WW, Krogh J, et al. Autoimmune diseases and severe infections as risk factors for mood disorders. JAMA Psychiatry. 2013;70:812.","journal-title":"JAMA Psychiatry"},{"key":"3532_CR175","doi-asserted-by":"publisher","unstructured":"Lee C-H, Giuliani F The role of inflammation in depression and fatigue. Front Immunol 2019;10. https:\/\/doi.org\/10.3389\/fimmu.2019.01696.","DOI":"10.3389\/fimmu.2019.01696"},{"key":"3532_CR176","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/mp.2016.167","volume":"23","author":"N Kappelmann","year":"2018","unstructured":"Kappelmann N, Lewis G, Dantzer R, Jones PB, Khandaker GM. Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions. Mol Psychiatry. 2018;23:335\u201343.","journal-title":"Mol Psychiatry"},{"key":"3532_CR177","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bbi.2024.02.019","volume":"118","author":"S Poletti","year":"2024","unstructured":"Poletti S, Zanardi R, Mandelli A, Aggio V, Finardi A, Lorenzi C, et al. Low-dose interleukin 2 antidepressant potentiation in unipolar and bipolar depression: safety, efficacy, and immunological biomarkers. Brain Behav Immun. 2024;118:52\u201368.","journal-title":"Brain Behav Immun"},{"key":"3532_CR178","doi-asserted-by":"publisher","first-page":"CD008012","DOI":"10.1002\/14651858.CD008012.pub4","volume":"12","author":"PJ Tully","year":"2021","unstructured":"Tully PJ, Ang SY, Lee EJ, Bendig E, Bauerei\u00df N, Bengel J, et al. Psychological and pharmacological interventions for depression in patients with coronary artery disease. Cochrane Database Syst Rev. 2021;12:CD008012. https:\/\/doi.org\/10.1002\/14651858.CD008012.pub4.","journal-title":"Cochrane Database Syst Rev"},{"key":"3532_CR179","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s11606-011-1704-y","volume":"26","author":"JL Grenard","year":"2011","unstructured":"Grenard JL, Munjas BA, Adams JL, Suttorp M, Maglione M, McGlynn EA, et al. Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis. J Gen Intern Med. 2011;26:1175\u201382.","journal-title":"J Gen Intern Med"},{"key":"3532_CR180","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s10072-012-1170-2","volume":"33","author":"IZ Basta","year":"2012","unstructured":"Basta IZ, Pekmezovi\u0107 TD, Peri\u0107 SZ, Kisi\u0107-Tepav\u010devi\u0107 DB, Rako\u010devi\u0107-Stojanovi\u0107 VM, Stevi\u0107 ZD, et al. Assessment of health-related quality of life in patients with myasthenia gravis in Belgrade (Serbia). Neurol Sci. 2012;33:1375\u201381.","journal-title":"Neurol Sci"},{"key":"3532_CR181","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.msard.2018.03.009","volume":"22","author":"S Ozakbas","year":"2018","unstructured":"Ozakbas S, Turkoglu R, Tamam Y, Terzi M, Taskapilioglu O, Yucesan C, et al. Prevalence of and risk factors for cognitive impairment in patients with relapsing-remitting multiple sclerosis: multi-center, controlled trial. Mult Scler Relat Disord. 2018;22:70\u201376.","journal-title":"Mult Scler Relat Disord"},{"key":"3532_CR182","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jneuroim.2016.02.011","volume":"293","author":"Z Shi","year":"2016","unstructured":"Shi Z, Chen H, Lian Z, Liu J, Feng H, Zhou H. Factors that impact health-related quality of life in neuromyelitis optica spectrum disorder: anxiety, disability, fatigue and depression. J Neuroimmunol. 2016;293:54\u201358.","journal-title":"J Neuroimmunol"},{"key":"3532_CR183","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.comppsych.2011.07.003","volume":"53","author":"L Renwick","year":"2012","unstructured":"Renwick L, Jackson D, Foley S, Owens E, Ramperti N, Behan C, et al. Depression and quality of life in first-episode psychosis. Compr Psychiatry. 2012;53:451\u20135.","journal-title":"Compr Psychiatry"},{"key":"3532_CR184","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/15622975.2022.2112074","volume":"24","author":"W Marx","year":"2023","unstructured":"Marx W, Manger SH, Blencowe M, Murray G, Ho FY-Y, Lawn S, et al. Clinical guidelines for the use of lifestyle-based mental health care in major depressive disorder: world federation of societies for biological psychiatry (WFSBP) and australasian society of lifestyle medicine (ASLM) taskforce. World J Biol Psychiatry. 2023;24:333\u201386.","journal-title":"World J Biol Psychiatry"},{"key":"3532_CR185","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/0004867420979353","volume":"55","author":"GS Malhi","year":"2021","unstructured":"Malhi GS, Bell E, Bassett D, Boyce P, Bryant R, Hazell P, et al. The 2020 royal australian and new zealand college of psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry. 2021;55:7\u2013117.","journal-title":"Aust N Z J Psychiatry"},{"key":"3532_CR186","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2165\/00023210-200216070-00002","volume":"16","author":"B Bagert","year":"2002","unstructured":"Bagert B, Camplair P, Bourdette D. Cognitive dysfunction in multiple sclerosis. CNS Drugs. 2002;16:445\u201355.","journal-title":"CNS Drugs"},{"key":"3532_CR187","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/da.22842","volume":"36","author":"ID Morres","year":"2019","unstructured":"Morres ID, Hatzigeorgiadis A, Stathi A, Comoutos N, Arpin-Cribbie C, Krommidas C, et al. Aerobic exercise for adult patients with major depressive disorder in mental health services: a systematic review and meta-analysis. Depress Anxiety. 2019;36:39\u201353.","journal-title":"Depress Anxiety"},{"key":"3532_CR188","doi-asserted-by":"publisher","unstructured":"Xie Y, Wu Z, Sun L, Zhou L, Wang G, Xiao L et al. The effects and mechanisms of exercise on the treatment of depression. Front Psychiatry 2021;12. https:\/\/doi.org\/10.3389\/fpsyt.2021.705559.","DOI":"10.3389\/fpsyt.2021.705559"},{"key":"3532_CR189","doi-asserted-by":"publisher","first-page":"101504","DOI":"10.1016\/j.berh.2020.101504","volume":"34","author":"GS Metsios","year":"2020","unstructured":"Metsios GS, Moe RH, Kitas GD. Exercise and inflammation. Best Pract Res Clin Rheumatol. 2020;34:101504.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"3532_CR190","doi-asserted-by":"publisher","first-page":"165823","DOI":"10.1016\/j.bbadis.2020.165823","volume":"1866","author":"DL da Scheffer","year":"2020","unstructured":"da Scheffer DL, Latini A. Exercise-induced immune system response: anti-inflammatory status on peripheral and central organs. Biochim Biophys Acta Mol Basis Dis. 2020;1866:165823.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"3532_CR191","doi-asserted-by":"publisher","first-page":"e1132","DOI":"10.1038\/tp.2017.76","volume":"7","author":"F Euteneuer","year":"2017","unstructured":"Euteneuer F, Dannehl K, del Rey A, Engler H, Schedlowski M, Rief W. Immunological effects of behavioral activation with exercise in major depression: an exploratory randomized controlled trial. Transl Psychiatry. 2017;7:e1132.","journal-title":"Transl Psychiatry"},{"key":"3532_CR192","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.biopsycho.2018.01.015","volume":"133","author":"EM Paolucci","year":"2018","unstructured":"Paolucci EM, Loukov D, Bowdish DME, Heisz JJ. Exercise reduces depression and inflammation but intensity matters. Biol Psychol. 2018;133:79\u201384.","journal-title":"Biol Psychol"},{"key":"3532_CR193","doi-asserted-by":"publisher","first-page":"107322","DOI":"10.1016\/j.phrs.2024.107322","volume":"207","author":"Y Yin","year":"2024","unstructured":"Yin Y, Ju T, Zeng D, Duan F, Zhu Y, Liu J, et al. \u201cInflamed\u201d depression: a review of the interactions between depression and inflammation and current anti-inflammatory strategies for depression. Pharmacol Res. 2024;207:107322.","journal-title":"Pharmacol Res"},{"key":"3532_CR194","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s11481-012-9398-4","volume":"7","author":"TJ Rogers","year":"2012","unstructured":"Rogers TJ. The molecular basis for neuroimmune receptor signaling. J Neuroimmune Pharmacol. 2012;7:722\u20134.","journal-title":"J Neuroimmune Pharmacol"},{"key":"3532_CR195","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.4049\/jimmunol.1201133","volume":"190","author":"M de las Casas-Engel","year":"2013","unstructured":"de las Casas-Engel M, Dom\u00ednguez-Soto A, Sierra-Filardi E, Bragado R, Nieto C, Puig-Kroger A, et al. Serotonin skews human macrophage polarization through HTR2B and HTR7. J Immunol. 2013;190:2301\u201310.","journal-title":"J Immunol"},{"key":"3532_CR196","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1189\/jlb.0906544","volume":"81","author":"I Clo\u00ebz-Tayarani","year":"2007","unstructured":"Clo\u00ebz-Tayarani I, Changeux J-P. Nicotine and serotonin in immune regulation and inflammatory processes: a perspective. J Leukoc Biol. 2007;81:599\u2013606.","journal-title":"J Leukoc Biol"},{"key":"3532_CR197","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1017\/S0033291718001356","volume":"49","author":"F Palhano-Fontes","year":"2019","unstructured":"Palhano-Fontes F, Barreto D, Onias H, Andrade KC, Novaes MM, Pessoa JA, et al. Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial. Psychol Med. 2019;49:655\u201363.","journal-title":"Psychol Med"},{"key":"3532_CR198","doi-asserted-by":"crossref","unstructured":"Bellini M, Fornai M, Usai Satta P, Bronzini F, Bassotti G, Blandizzi C, et al. The role of serotonin and its pathways in gastrointestinal disorders. In: The complex interplay between gut-brain, gut-liver, and liver-brain axes. France: Elsevier; 2021. pp 67\u201394.","DOI":"10.1016\/B978-0-12-821927-0.00009-7"},{"key":"3532_CR199","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-03208-z","volume":"14","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Qu Y, Shi L, Ou M, Du Z, Zhou Z, et al. The role of gut microbiota and metabolomic pathways in modulating the efficacy of SSRIs for major depressive disorder. Transl Psychiatry. 2024;14:493.","journal-title":"Transl Psychiatry"},{"key":"3532_CR200","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1046\/j.1440-1711.2003.t01-1-01177.x","volume":"81","author":"JR Moffett","year":"2003","unstructured":"Moffett JR, Namboodiri MA. Tryptophan and the immune response. Immunol Cell Biol. 2003;81:247\u201365.","journal-title":"Immunol Cell Biol"},{"key":"3532_CR201","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1084\/jem.20120408","volume":"209","author":"EC Nowak","year":"2012","unstructured":"Nowak EC, de Vries VC, Wasiuk A, Ahonen C, Bennett KA, Le Mercier I, et al. Tryptophan hydroxylase-1 regulates immune tolerance and inflammation. J Exp Med. 2012;209:2127\u201335.","journal-title":"J Exp Med"},{"key":"3532_CR202","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0014-5793(04)00079-1","volume":"560","author":"HJ Welters","year":"2004","unstructured":"Welters HJ, Tadayyon M, Scarpello JHB, Smith SA, Morgan NG. Mono-unsaturated fatty acids protect against beta-cell apoptosis induced by saturated fatty acids, serum withdrawal or cytokine exposure. FEBS Lett. 2004;560:103\u20138.","journal-title":"FEBS Lett"},{"key":"3532_CR203","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.cell.2016.10.017","volume":"167","author":"Y Li","year":"2016","unstructured":"Li Y, Oosting M, Smeekens SP, Jaeger M, Aguirre-Gamboa R, Le KTT. et al. A functional genomics approach to understand variation in cytokine production in humans. Cell. 2016;167:1099\u2013110.e14","journal-title":"Cell"},{"key":"3532_CR204","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1172\/JCI30555","volume":"117","author":"KJ Tracey","year":"2007","unstructured":"Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest. 2007;117:289\u201396.","journal-title":"J Clin Invest"},{"key":"3532_CR205","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fnins.2018.00049","volume":"12","author":"B Bonaz","year":"2018","unstructured":"Bonaz B, Bazin T, Pellissier S. The vagus nerve at the interface of the microbiota-gut-brain axis. Front Neurosci. 2018;12:49. https:\/\/doi.org\/10.3389\/fnins.2018.00049.","journal-title":"Front Neurosci"},{"key":"3532_CR206","doi-asserted-by":"publisher","first-page":"e2023285119","DOI":"10.1073\/pnas.2023285119","volume":"119","author":"AS Caravaca","year":"2022","unstructured":"Caravaca AS, Gallina AL, Tarnawski L, Shavva VS, Colas RA, Dalli J, et al. Vagus nerve stimulation promotes resolution of inflammation by a mechanism that involves Alox15 and requires the \u03b17nAChR subunit. Proc Natl Acad Sci USA. 2022;119:e2023285119. https:\/\/doi.org\/10.1073\/pnas.2023285119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3532_CR207","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/nmo.12792","volume":"28","author":"B Bonaz","year":"2016","unstructured":"Bonaz B, Sinniger V, Hoffmann D, Claren\u00e7on D, Mathieu N, Dantzer C, et al. Chronic vagus nerve stimulation in Crohn\u2019s disease: a 6\u2010month follow\u2010up pilot study. Neurogastroenterol Motil. 2016;28:948\u201353.","journal-title":"Neurogastroenterol Motil"},{"key":"3532_CR208","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1016\/j.neuron.2022.09.003","volume":"110","author":"VA Pavlov","year":"2022","unstructured":"Pavlov VA, Tracey KJ. Bioelectronic medicine: preclinical insights and clinical advances. Neuron. 2022;110:3627\u201344.","journal-title":"Neuron"},{"key":"3532_CR209","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s42234-022-00100-3","volume":"8","author":"A Falvey","year":"2022","unstructured":"Falvey A. Vagus nerve stimulation and inflammation: expanding the scope beyond cytokines. Bioelectron Med. 2022;8:19.","journal-title":"Bioelectron Med"},{"key":"3532_CR210","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2005-03-0979","volume":"106","author":"D Braun","year":"2005","unstructured":"Braun D, Longman RS, Albert ML. A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation. Blood. 2005;106:2375\u201381.","journal-title":"Blood"},{"key":"3532_CR211","doi-asserted-by":"publisher","first-page":"6773","DOI":"10.1038\/s41380-021-01160-8","volume":"26","author":"A Borsini","year":"2021","unstructured":"Borsini A, Nicolaou A, Camacho-Mu\u00f1oz D, Kendall AC, Di Benedetto MG, Giacobbe J, et al. Omega-3 polyunsaturated fatty acids protect against inflammation through production of LOX and CYP450 lipid mediators: relevance for major depression and for human hippocampal neurogenesis. Mol Psychiatry. 2021;26:6773\u201388.","journal-title":"Mol Psychiatry"},{"key":"3532_CR212","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1590\/S0100-879X2008001200001","volume":"41","author":"CD Munhoz","year":"2008","unstructured":"Munhoz CD, Garc\u00eda-Bueno B, Madrigal JLM, Lepsch LB, Scavone C, Leza JC. Stress-induced neuroinflammation: mechanisms and new pharmacological targets. Braz J Med Biol Res. 2008;41:1037\u201346.","journal-title":"Braz J Med Biol Res"},{"key":"3532_CR213","doi-asserted-by":"publisher","first-page":"107625","DOI":"10.1016\/j.pharmthera.2020.107625","volume":"215","author":"O K\u00f6hler-Forsberg","year":"2020","unstructured":"K\u00f6hler-Forsberg O, Otte C, Gold SM, \u00d8stergaard SD. Statins in the treatment of depression: hype or hope? Pharmacol Ther. 2020;215:107625.","journal-title":"Pharmacol Ther"},{"key":"3532_CR214","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1177\/03946320140270S103","volume":"27","author":"G Lapadula","year":"2014","unstructured":"Lapadula G, Marchesoni A, Armuzzi A, Blandizzi C, Caporali R, Chimenti S, et al. Adalimumab in the treatment of immune-mediated diseases. Int J Immunopathol Pharmacol. 2014;27:33\u201348.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"3532_CR215","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.bbi.2023.04.010","volume":"111","author":"R De Marco","year":"2023","unstructured":"De Marco R, Barritt AW, Cercignani M, Cabbai G, Colasanti A, Harrison NA. Inflammation-induced reorientation of reward versus punishment sensitivity is attenuated by minocycline. Brain Behav Immun. 2023;111:320\u20137.","journal-title":"Brain Behav Immun"},{"key":"3532_CR216","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1503\/jpn.100057","volume":"36","author":"O Dean","year":"2011","unstructured":"Dean O, Giorlando F, Berk M. N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action. J Psychiatry Neurosci. 2011;36:78\u201386.","journal-title":"J Psychiatry Neurosci"},{"key":"3532_CR217","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.neubiorev.2015.04.015","volume":"55","author":"Deepmala","year":"2015","unstructured":"Deepmala, Slattery J, Kumar N, Delhey L, Berk M, Dean O, et al. Clinical trials of N-acetylcysteine in psychiatry and neurology: a systematic review. Neurosci Biobehav Rev. 2015;55:294\u2013321.","journal-title":"Neurosci Biobehav Rev"},{"key":"3532_CR218","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.bbi.2012.07.003","volume":"26","author":"MA Erickson","year":"2012","unstructured":"Erickson MA, Hansen K, Banks WA. Inflammation-induced dysfunction of the low-density lipoprotein receptor-related protein-1 at the blood\u2013brain barrier: protection by the antioxidant N-acetylcysteine. Brain Behav Immun. 2012;26:1085\u201394.","journal-title":"Brain Behav Immun"},{"key":"3532_CR219","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1189\/jlb.0212100","volume":"92","author":"W Beumer","year":"2012","unstructured":"Beumer W, Gibney SM, Drexhage RC, Pont-Lezica L, Doorduin J, Klein HC, et al. The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes. J Leukoc Biol. 2012;92:959\u201375.","journal-title":"J Leukoc Biol"},{"key":"3532_CR220","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s44184-024-00054-1","volume":"3","author":"S Xue","year":"2024","unstructured":"Xue S, Massazza A, Akhter-Khan SC, Wray B, Husain MI, Lawrance EL. Mental health and psychosocial interventions in the context of climate change: a scoping review. npj Ment Health Res. 2024;3:10.","journal-title":"npj Ment Health Res"},{"key":"3532_CR221","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-57282-w","volume":"14","author":"J Nonweiler","year":"2024","unstructured":"Nonweiler J, Vives J, Barrantes-Vidal N, Ballesp\u00ed S. Emotional self-knowledge profiles and relationships with mental health indicators support value in \u2018knowing thyself\u2019. Sci Rep. 2024;14:7900.","journal-title":"Sci Rep"},{"key":"3532_CR222","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-11655-1","volume":"12","author":"G Barbalat","year":"2022","unstructured":"Barbalat G, Plasse J, Gauthier E, Verdoux H, Quiles C, Dubreucq J, et al. The central role of self-esteem in the quality of life of patients with mental disorders. Sci Rep. 2022;12:7852.","journal-title":"Sci Rep"},{"key":"3532_CR223","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/nm1205-1259","volume":"11","author":"P Basu","year":"2005","unstructured":"Basu P. Spirituality\u2019s rising role in medicine stirs debate. Nat Med. 2005;11:1259\u20131259.","journal-title":"Nat Med"},{"key":"3532_CR224","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15964","volume":"8","author":"SQ Park","year":"2017","unstructured":"Park SQ, Kahnt T, Dogan A, Strang S, Fehr E, Tobler PN. A neural link between generosity and happiness. Nat Commun. 2017;8:15964.","journal-title":"Nat Commun"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03532-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03532-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03532-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T05:14:47Z","timestamp":1757481287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03532-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,23]]},"references-count":224,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3532"],"URL":"https:\/\/doi.org\/10.1038\/s41398-025-03532-y","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,23]]},"assertion":[{"value":"9 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"314"}}